The nation of Zimbabwe has turned down a major American health deal worth 367 million US dollars (272 million pounds) spanning five years due to the United States' demand for sensitive data.
This move became public following a official document dated December was disclosed, revealing that President Emmerson Mnangagwa felt the agreement was "lopsided".
A government spokesman later stated that the US was demanding access to biological samples for scientific study and profit while was unwilling to guarantee the resulting advantages from future medical innovations.
"We must now begin the challenging and unfortunate process of scaling back our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had furnished over $1.9bn for health programmes to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has called for more dialogue to reach a deal suitable to both sides so the country's critical HIV treatment initiative can proceed.
Wider Background
Zimbabwe's decision comes after a comparable situation in Kenya, where a high court halted a similar deal with the US after legal challenges were filed about the safety of citizens' health data.
After returning to the presidency recently, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.
The agency had administered assistance for the US government, but Trump claimed its expenditure was "inefficient" and his administration was pursuing government-to-government agreements to enhance openness and accountability.
Based on statements, 16 African countries have so far signed these new agreements, constituting over $18.3bn in new funding.
Specifics of the Rejected Agreement
This assistance for Zimbabwe would have funded "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this cooperation could have provided significant advantages for Zimbabwean communities, particularly the 1.2 million presently on antiretroviral therapy through American-funded programmes," the Ambassador added.
However, official spokesman Nick Mangwana argued the proposed deal was "unequal".
"Zimbabwe was being asked to provide its biological resources and data over an extended period, with no equivalent promise of access to any medical innovations – like vaccines, diagnostics, or treatments – that could be developed from that shared data," he stated.
"Effectively, our nation would supply the raw materials for medical research with no certainty that the resulting innovations would be available to our citizens if a new disease outbreak arise."
Sovereignty and International Frameworks
Mangwana further said that the American exit from the World Health Organization (WHO) and its pursuit of bilateral health agreements were disrupting systems already established through the international health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system designed to manage future global health emergencies.
"This system is intended to ensure that when a country contributes its data, the resulting advantages – including medicines and cures – are shared equitably, not monopolised exclusively by those with the resources to create them."
Zimbabwe's reservations over the US deal "are not meant as hostility towards the US," Mangwana stressed.
"We are open to continued discussions with our US partners on how future co-operation might be arranged in a manner that respects the independence and dignity of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the official position, but urged that talks should continue considering much of the nation's HIV programmes were funded by external financing.
"Where specific concerns arise, including those involving information security or agreement terms, these can frequently be addressed through technical clarification and mutually agreed protections," it said.
This impasse emphasises the ongoing tensions between accepting much-needed foreign assistance and protecting local interests in an ever more data-driven world.